Advertisement
MET vs MFC
Which Stock Would AI Choose? MetLife (MET) vs. Manulife Financial (MFC) Stock Comparison
Key Takeaways
- MET and MFC are both large, diversified life insurers, but they carry meaningfully different geographic and growth profiles.
- MetLife has posted strong recent momentum, with adjusted return on equity (ROE, a measure of profitability) near 17% and a year-to-date share gain above 20%.
- Manulife is anchored by rapid growth in Asia, where core earnings rose about 22% in its latest quarter, though its wealth and asset management arm saw net outflows.
- MetLife trades at a premium earnings multiple relative to the broader insurance group, while Manulife offers a lower valuation with a sizable share-buyback and dividend program.
- Relative performance and trend consistency currently appear stronger for MET, though MFC's Asia franchise remains a differentiated long-term growth driver.
Introduction
MetLife (NYSE: MET) and Manulife Financial (NYSE/TSE: MFC) are two of the largest publicly traded life and health insurers in North America. Both operate across insurance, retirement, and asset management, yet their earnings engines are built differently. This stock comparison is most relevant for investors and traders evaluating the life insurance sector who want to weigh a U.S.-centric, group-benefits-heavy franchise against a Canada-based operator leveraged to Asian growth. Understanding the relative performance, market positioning, and recent catalysts behind each name can help frame which business is better suited to the current macro environment.
MET Overview and Recent Performance
MetLife, Inc. (MET) is a global provider of insurance, annuities, employee benefits, and asset management services. Its core businesses include Group Benefits, Retirement and Income Solutions (RIS), a sizable Asia franchise, and MetLife Investment Management. In recent quarters, the company has delivered broad-based growth under its "New Frontier" strategy, with adjusted earnings rising across nearly all segments and adjusted ROE reaching roughly 17%, at the top of its 15% to 17% target range.
Recent market activity has been favorable, with the stock advancing more than 20% year to date and trading near record territory. Favorable life-mortality trends, volume growth in Group Benefits, and strength in Asia and EMEA (Europe, the Middle East, and Africa) have supported sentiment. Analysts have issued mixed target revisions, with some raising estimates while others trimmed targets on valuation. The shares trade at an earnings multiple above the broader insurance peer average, reflecting investor confidence in the franchise's execution and earnings quality.
MFC Overview and Recent Performance
Manulife Financial Corporation (MFC) is a Canada-headquartered insurer and wealth manager operating through its Asia segment, Canada, the U.S. (under the John Hancock brand), and Global Wealth and Asset Management (WAM). Its most recent results highlighted the durability of its Asian operations, where core earnings grew about 22% year over year, alongside double-digit growth in new business value (NBV, a measure of the profitability of new policies sold).
However, the picture is more mixed elsewhere. Global WAM posted net outflows of roughly $4.4 billion in its latest quarter, driven by redemptions in North American active mutual funds and U.S. retirement accounts, while the Canada segment faced less favorable group insurance claims experience. Core ROE improved to about 16.5%, and the company's LICAT ratio (Life Insurance Capital Adequacy Test, a Canadian solvency measure) remained strong at 136%. The stock has gained roughly 9% to 10% year to date, a solid but more measured advance than some peers.
Trending AI Robots
For traders looking to systematize this kind of relative analysis, Tickeron's Trending AI Robots page offers a curated view of AI-driven trading strategies. Tickeron hosts hundreds of AI Trading Bots that collectively trade thousands of different tickers, but only those best suited to current market conditions earn a place in this rotating selection. Each bot operates with its own trading style, strategy, timeframe, performance history, and set of tickers, so the featured list reflects a range of approaches rather than a single market view. Exploring the Trending AI Robots section can help traders identify data-driven strategies aligned with the market's prevailing conditions.
Head-to-Head Comparison
The clearest contrast between these two insurers is geographic mix. MET generates a large share of earnings from U.S. Group Benefits and Retirement and Income Solutions, giving it broad exposure to domestic employment trends and pension risk transfer activity. MFC, by contrast, leans on Asia as its primary growth engine, supplemented by a substantial wealth and asset management business that is more sensitive to fund flows and equity markets.
Growth drivers differ as well. MetLife has benefited from exceptionally favorable mortality and underwriting, disciplined expense control, and higher investment income in a higher-rate environment. Manulife's momentum is tied to Asian insurance demand, new business value expansion, and its evolving asset management platform, though retail fund outflows remain a near-term headwind. On risk factors, MetLife carries valuation risk after its strong run, while Manulife faces flow volatility and mixed group insurance experience. Both maintain solid capital positions, though MetLife's earnings multiple is notably richer than the sector, whereas Manulife screens as comparatively cheaper.
Tickeron AI Verdict
Based on observable factors such as trend consistency, earnings momentum, and relative positioning, Tickeron's AI would likely favor MET in the current environment. MetLife's combination of rising adjusted earnings, top-of-range ROE, broad segment strength, and a steady uptrend gives it more consistent momentum and a clearer near-term catalyst path. Manulife's Asia franchise remains a compelling structural story, but softer flows in Global WAM and uneven group insurance results introduce more variability. This assessment is probabilistic rather than definitive, reflecting relative strength in current market conditions rather than a long-term judgment on either franchise.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MET is a Buy and MFC is a StrongBuy.
MET in +2.36% Uptrend, advancing for three consecutive days on October 22, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MET advanced for three days, in 224 of 344 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on MET as a result. In 45 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 54%.
The Moving Average Convergence Divergence (MACD) for MET just turned positive on October 08, 2026. Looking at past instances where MET's MACD turned positive, the stock continued to rise in 28 of 51 cases over the following month. The odds of a continued upward trend are 55%.
MET moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MET crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
Bearish Trend Analysis
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
MET broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MET entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 15 (best 1 - 100 worst), indicating outstanding price growth. MET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 19 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MET's P/B Ratio (2.366) is slightly higher than the industry average of (1.347). P/E Ratio (19.426) is within average values for comparable stocks, (19.840). Projected Growth (PEG Ratio) (0.506) is also within normal values, averaging (0.463). Dividend Yield (0.023) settles around the average of (0.046) among similar stocks. P/S Ratio (0.824) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
MFC's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for MFC turned positive on October 15, 2026. Looking at past instances where MFC's MACD turned positive, the stock continued to rise in 34 of 46 cases over the following month. The odds of a continued upward trend are 74%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on MFC as a result. In 50 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
MFC moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MFC crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 44%.
Following a +2.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where MFC advanced for three days, in 223 of 350 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
The Aroon Indicator entered an Uptrend today. In 199 of 354 cases where MFC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 56%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MFC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.
MFC broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 4 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. MFC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.609) is normal, around the industry mean (1.347). P/E Ratio (12.232) is within average values for comparable stocks, (19.840). Projected Growth (PEG Ratio) (0.876) is also within normal values, averaging (0.463). Dividend Yield (0.031) settles around the average of (0.046) among similar stocks. P/S Ratio (1.780) is also within normal values, averaging (1.303).
The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
MET | MFC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 44 | 21 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 55 Fair valued | 51 Fair valued | |
PROFIT vs RISK RATING 1..100 | 19 | 4 | |
SMR RATING 1..100 | 99 | 100 | |
PRICE GROWTH RATING 1..100 | 15 | 41 | |
P/E GROWTH RATING 1..100 | 11 | 59 | |
SEASONALITY SCORE 1..100 | 50 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MFC's Valuation (51) in the Life Or Health Insurance industry is in the same range as MET (55). This means that MFC’s stock grew similarly to MET’s over the last 12 months.
MFC's Profit vs Risk Rating (4) in the Life Or Health Insurance industry is in the same range as MET (19). This means that MFC’s stock grew similarly to MET’s over the last 12 months.
MET's SMR Rating (99) in the Life Or Health Insurance industry is in the same range as MFC (100). This means that MET’s stock grew similarly to MFC’s over the last 12 months.
MET's Price Growth Rating (15) in the Life Or Health Insurance industry is in the same range as MFC (41). This means that MET’s stock grew similarly to MFC’s over the last 12 months.
MET's P/E Growth Rating (11) in the Life Or Health Insurance industry is somewhat better than the same rating for MFC (59). This means that MET’s stock grew somewhat faster than MFC’s over the last 12 months.
| MET | MFC | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 55% | 1 day ago 51% |
| Stochastic ODDS (%) | 1 day ago 57% | 1 day ago 44% |
| Momentum ODDS (%) | 1 day ago 54% | 1 day ago 65% |
| MACD ODDS (%) | 1 day ago 55% | 1 day ago 74% |
| TrendWeek ODDS (%) | 1 day ago 60% | 1 day ago 60% |
| TrendMonth ODDS (%) | 1 day ago 54% | 1 day ago 56% |
| Advances ODDS (%) | 1 day ago 65% | 1 day ago 64% |
| Declines ODDS (%) | 23 days ago 52% | 16 days ago 50% |
| BollingerBands ODDS (%) | 1 day ago 64% | 1 day ago 40% |
| Aroon ODDS (%) | 1 day ago 47% | 1 day ago 56% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MET’s FA Score shows that 3 FA rating(s) are green while MFC’s FA Score has 1 green FA rating(s).
- MET’s FA Score: 3 green, 2 red.
- MFC’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MET’s TA Score shows that 5 TA indicator(s) are bullish while MFC’s TA Score has 6 bullish TA indicator(s).
- MET’s TA Score: 5 bullish, 5 bearish.
- MFC’s TA Score: 6 bullish, 4 bearish.
Price Growth
MET (@Life/Health Insurance) experienced а +3.29% price change this week, while MFC (@Life/Health Insurance) price change was +4.01% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +3.54%. For the same industry, the average monthly price growth was -0.35%, and the average quarterly price growth was -1.67%.
Reported Earning Dates
MET is expected to report earnings on Nov 04, 2026.
MFC is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Life/Health Insurance (+3.54% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
Advertisement